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Abstract
Background: Health status, dyspnea and psychological status are important clinical outcomes in chronic
obstructive pulmonary disease (COPD). However, forced expiratory volume in one second (FEV1) measured by
spirometry, the standard measurement of airflow limitation, has only a weak relationship with these outcomes in
COPD. Recently, in addition to spirometry, impulse oscillometry (IOS) measuring lung resistance (R) and reactance
(X) is increasingly being used to assess pulmonary functional impairment.
Methods: We aimed to identify relationships between IOS measurements and patient-reported outcomes in 65
outpatients with stable COPD. We performed pulmonary function testing, IOS, high-resolution computed
tomography (CT), and assessment of health status using the St. George’s Respiratory Questionnaire (SGRQ), dyspnea
using the Medical Research Council (MRC) scale and psychological status using the Hospital Anxiety and
Depression Scale (HADS). We then investigated the relationships between these parameters. For the IOS
measurements, we used lung resistance at 5 and 20 Hz (R5 and R20, respectively) and reactance at 5 Hz (X5).
Because R5 and R20 are regarded as reflecting total and proximal airway resistance, respectively, the fall in
resistance from R5 to R20 (R5-R20) was used as a surrogate for the resistance of peripheral airways. X5 was also
considered to represent peripheral airway abnormalities.
Results: R5-R20 and X5 were significantly correlated with the SGRQ and the MRC. These correlation coefficients
were greater than when using other objective measurements of pulmonary function, R20 on the IOS and CT
instead of R5-R20 and X5. Multiple regression analyses showed that R5-R20 or X5 most significantly accounted for
the SGRQ and MRC scores.
Conclusions: IOS measurements, especially indices of peripheral airway function, are significantly correlated with
health status and dyspnea in patients with COPD. Therefore, in addition to its simplicity and non-invasiveness, IOS
may be a useful clinical tool not only for detecting pulmonary functional impairment, but also to some extent at
least estimating the patient’s quality of daily life and well-being.
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Health status, dyspnea and psychological status of anxi-
ety and depression are important outcomes in chronic
obstructive pulmonary disease (COPD). Improved health
status and relief of symptoms are listed as the goals of
effective management in the Global Initiative for
Chronic Obstructive Lung Disease (GOLD) [1].
Mortality is also an important outcome in COPD as it
is ranked as high as a cause of death in the world [1].
The above-mentioned patient-reported outcomes can
significantly predict mortality independently of airflow
limitation evaluated by forced expiratory volume in one
second (FEV1) [2-4]. In fact, previous reports indicate
that there are only weak correlations between these out-
comes and FEV1 [5-8].
Recent studies suggest that impulse oscillometry (IOS)
can detect airway abnormalities better than spirometry
for assessing pulmonary function in COPD [9,10], adult
asthma [11-13], and dust exposure [14,15]. IOS mea-
sures lung resistance and reactance, and is a clinically
promising method which is simple and non-invasive and
does not require forced maneuvers [16,17].
Comparing FEV1 by spirometry and IOS, while FEV1
mainly measures expiratory flow at high and mid lung
volumes [18], IOS can usefully measure both large and
small airway resistance separately [14-17]. This feature
of IOS may be important because the involvement of
small airways in COPD is indicated [19-21].
In assessing COPD, high-resolution computed tomo-
graphy (CT) also provides valuable information concern-
ing parenchymal destruction and airway lesions. We
have assessed the severity of emphysema by measuring
the low attenuation area (LAA), and airway dimensions
including evaluation of the luminal area and airway wall
thickness of the right upper apical bronchus [22].
We hypothesized that there would be significant asso-
ciations between patient- reported outcomes and pul-
monary impairments evaluated with IOS in patients
with COPD. Here, we performed a cross-sectional study
evaluating three different objective assessments consist-
ing of conventional pulmonary function tests, IOS and
CT, and compared them with subjective measurements
of health status, dyspnea and psychological status in
patients with COPD.
Methods
Subjects
We recruited 65 male outpatients with stable COPD,
defined by the GOLD [1], at Kyoto University Hospital.
The eligibility criteria included: 1) smoking history of
more than 20 pack-years; 2) maximal FEV1/forced vital
capacity (FVC) ratio of less than 0.7; 3) regular manage-
ment and treatment at our outpatient clinic over 6
months; 4) no exacerbations in the previous 6 weeks; 5)
no other lung diseases; 6) no uncontrolled comorbidities
such as severe cardiovascular diseases and malignant
disorders; and 7) having sufficient cognitive function to
complete the questionnaire. Pulmonary function, IOS,
CT, health status, dyspnea, and psychological status
were assessed on the same day. The research protocol
was approved by the Ethics Committee of Kyoto Univer-
sity and the subjects gave written informed consent.
Outcome measures
Pulmonary function
Spirometry was performed according to the recom-
mended method, as reported previously [2,6,7]. Residual
volume (RV) and total lung capacity (TLC) were mea-
sured by the closed-circuit helium method, and carbon
monoxide diffusing capacity (DLCO) was measured using
a single-breath technique.
IOS
The impedance of the total respiratory system was mea-
sured using IOS (Erich Jaeger, Germany). Subjects
underwent IOS and then spirometry 15 minutes after
inhaling the bronchodilators salbutamol (400 μg) and
ipratropium bromide (80 μg) [2,6,7]. The superimposed
pressure oscillations during normal-volume spontaneous
breathing are composed of several frequencies, allowing
the assessment of resistance (R) and reactance (X) at
several frequencies simultaneously. The frequency range
of the signal was from 5 to 35 Hz. Subjects supported
their cheeks to reduce upper airway shunting while
impulses were applied during tidal breathing for 30 sec-
onds. In the present study, we used respiratory resis-
tance at 5 and 20 Hz (R5 and R20, respectively) and
reactance at 5 Hz (X5) for the analyses. R5 and R20 are
regarded as reflecting total and proximal airway resis-
tance, respectively, and the fall in resistance from R5 to
R20 (R5-R20) was used as a surrogate for the resistance
of peripheral airways, as reported previously
[14-17,23-27]. Furthermore, X5, which may be deter-
mined by homogeneous distribution of ventilation, effec-
tive ventilation capacity, and compliance of the lung and
chest wall, was also considered to represent peripheral
airway abnormalities such as those caused by inflamma-
tion [15-17,23-25]. X5 was recently reported to be a use-
ful and informative measurement due to its close
relationship with conventional pulmonary function
assessments in COPD [28].
CT
CT images were obtained using a multi-detector row
s c a n n e r( A q u i l i o n6 4 ;T o s h i b a ,T o k y o ,J a p a n )w i t h
simultaneous acquisition of sixty-four 0.5 mm sections.
Technical parameters were as follows: voltage 120 kVp,
automatic electric current control, field of view
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Page 2 of 7350 mm, reconstruction algorithm, lung algorithm with
automatic correction of beam hardening effect. Percen-
tages of LAA (LAA%) were analyzed according to a
modified method that was previously reported from our
department [29]. Unlike the original method, in the cur-
rent study, we used multi-detector computed tomogra-
p h y( M D C T )t h a tp r o v i d e du sw i t hm a n ys l i c e s ,b u t
without additional radiation exposure. Therefore, we
used the slices from the upper margin of the aortic arch
to the diaphragm to analyze LAA%. Areas where CT
numbers were less than -200 HU were defined as lung
fields, and the cut-off level between LAA and normal
lung density was defined as -960 HU [22,30].
For the analysis of airway dimensions, the right upper
apical bronchus was measured in each subject using the
method we had previously reported [22,30,31]. The area
of the inner lumen and thickness of the airway wall was
measured automatically from CT images. The diameter
of the airway, the outer area of the airway, airway wall
area (WA), and percentage wall area (WA%) were calcu-
lated from the area of the inner lumen and thickness of
the airway wall.
Health status
Health status was evaluated by the Japanese version of
the St. George’s Respiratory Questionnaire (SGRQ)
[2,6,7,32]. It contains 50 items divided into 3 compo-
nents of symptoms, activity and impacts, and a total
score was also calculated, with scores ranging from 0 to
100. Lower scores indicate less impairment on the
SGRQ.
Dyspnea
Severity of dyspnea was evaluated by the Japanese ver-
sion of the modified Medical Research Council (MRC)
scale [6,7,33], which consists of a 5-point scale based on
degrees of various physical activities that precipitate dys-
pnea. Lower scores indicate less impairment on the
MRC scale.
Psychological status
Psychological status was evaluated by the Japanese ver-
sion of the Hospital Anxiety and Depression Scale
(HADS) [6,7,34] which contains 14 items and consists of
two subscales: anxiety and depression. Each item is
r a t e do naf o u r - p o i n ts c a l e( 0 - 3 )w h e r eas c o r eo f3
represents the worst state of anxiety or depression.
Statistical analysis
Results are expressed as mean ± SD. Relationships
between different objective measurements (pulmonary
function testing, IOS and CT) and patient-reported out-
comes were evaluated using Pearson’s correlation coeffi-
cient tests. We have chosen to present all results as
Pearson’s correlation coefficients for ease of comprehen-
sion and comparison across relationships [35]. We also
tested for significant differences between two correlation
coefficients obtained from two different relationships in
the same samples [36]. Next, we performed forward and
backward stepwise multiple regression analyses to iden-
tify the variables that could best predict the health sta-
tus and dyspnea scores, using the measurements of
pulmonary function, IOS and CT as independent vari-
ables [6]. P values of less than 0.05 were considered to
be statistically significant. All analyses were performed
using the JMP (SAS Institute).
Results
Baseline characteristics
Baseline characteristics of the 65 male patients with
COPD are presented in Table 1. Of these, 11 (17.0%)
were current smokers. COPD severity based on the
GOLD [1] was mild in 12 patients (18.4%), moderate in
30 (46.2%), severe in 20 (30.8%), and very severe in the
remaining 3 patients (4.6%).
Relationships between IOS measurements, pulmonary
function and CT
We examined the relationships between IOS measure-
ments and other objective parameters of pulmonary
function and CT. R20 showed a weak or non-significant
correlation with R5-R20 and X5 (r (correlation coeffi-
cient) = 0.29, p = 0.020, and r = -0.19, p =0 . 1 3 ,
Table 1 Baseline characteristics (n = 65)
Characteristics Mean ± SD Range
Age (years) 71 ± 9 46 – 87
Height (m) 1.65 ± 0.06 1.50 – 1.80
Body mass index (kg/m
2) 21.3 ± 2.7 15.42 – 29.0
FEV1 (L) 1.64 ± 0.64 0.58 – 3.42
FEV1 (%predicted) 58.8 ± 19.7 18.7 – 100.8
RV/TLC (%) 42.9 ± 7.5 27.7 – 59.4
DLCO/VA(ml/min/mmHg/L) 2.76 ± 1.06 0.69 – 5.35
R20 (kPa/L/s) 0.24 ± 0.07 0.13 – 0.41
R5-R20 (kPa/L/s) 0.09 ± 0.06 -0.02 – 0.27
X5 (kPa/L/s) -0.15 ± 0.08 -0.48 – -0.05
LAA (%) 20.4 ± 10.2 2.5 – 44.5
WA (%) 57.1 ± 5.7 44.9 – 71.6
SGRQ symptoms (0–100) 35.0 ± 20.5 0 – 90.6
SGRQ activity (0–100) 41.2 ± 21.9 0 – 92.5
SGRQ impact (0–100) 20.1 ± 15.9 0 – 63.2
SGRQ total (0–100) 29.0 ± 16.4 1.6 – 62.3
MRC (0–4) 1.1 ± 0.8 0 – 4
HADS anxiety (0–21) 3.3 ± 3.0 0 – 12
HADS depression (0–21) 3.6 ± 2.9 0 – 12
Numbers in parentheses indicate theoretical score ranges.
FEV1 = forced expiratory volume in one second; RV = residual volume; TLC =
total lung capacity; DLCO = carbon monoxide diffusing capacity; VA = alveolar
volume R = resistance; X = reactance; LAA = low attenuation area; WA = wall
area; SGRQ = St. George’s Respiratory Questionnaire; MRC = Medical Research
Council; HADS = Hospital Anxiety and Depression Scale
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cal parameters from R5-R20 and X5. In contrast,
there was a strong association between R5-R20 and X5
(r = -0.87, p < 0.001), indicating that these two periph-
eral airway functional indices could reflect similar
events. R20 was significantly but weakly correlated with
FEV1 (r = -0.29, p = 0.018). R5-R20 and X5 were mod-
erately significantly correlated with FEV1 (r = -0.69,
p < 0.001 and r = 0.61, p < 0.001, respectively) and RV/
TLC (r = 0.49, p <0 . 0 0 1a n dr = -0.54, p <0 . 0 0 1 ,
respectively) and weakly with LAA% (r = 0.32, p = 0.010
and r = -0.37, p = 0.002, respectively).
Relationships between pulmonary function, IOS, CT and
patient-reported outcomes
Table 2 shows the correlation coefficients for pulmonary
function, IOS, CT and patient-reported outcomes. R5-
R20 and X5 on IOS were weakly to moderately corre-
lated with all three components (symptoms, activity and
impacts) and the total of the SGRQ and the MRC scores
(r = 0.31-0.51, p <0 . 0 1a n dr = 0.27-0.51, p <0 . 0 1 ,
respectively). These relationships were significantly
stronger than any other relationships for each compo-
nent and total of the SGRQ and MRC scores [36].
Results of multiple regression analyses to predict health
status and dyspnea
Table 3 shows the results of stepwise multiple regres-
sion analyses to identify variables that could best predict
health status and dyspnea. R5-R20 alone accounted for
the symptoms, impacts and total of the SGRQ signifi-
cantly (r
2 (coefficient of determination) = 0.09, 0.19 and
0.24, respectively). The relationship between R5-R20 and
t h et o t a lS G R Qi ss h o w ni nF i g u r e1 .T h ev a r i a n c eo f
the activity of the SGRQ was most significantly
accounted for by X5 (r
2 =0 . 2 6 ) ,a n df a rl e s ss ob yR V /
TLC (r
2 = 0.02). For the MRC scores, R5-R20 was the
most significant contributive factor (r
2 = 0.27), and LAA
%, FEV1,a n dR V / T L Cw e r ef o u n dt ob eo n l yw e a k l y
associated (r
2 = 0.06, 0.03 and 0.02, respectively).
Discussion
Here, we demonstrated that peripheral airway measure-
ments by IOS (R5-R20 and X5) were significantly corre-
lated with the SGRQ and MRC scores. No
measurements of pulmonary function, IOS and CT were
significantly correlated with the HADS. Multiple regres-
sion analyses revealed that R5-R20 or X5 accounted for
the SGRQ and MRC scores more significantly than
FEV1 and CT measurements (r
2 = 0.09 to 0.27). Thus,
the novel finding in this study is that peripheral airway
measurements by IOS were useful not only for assessing
pulmonary impairments but also because they have cer-
tain relationships with health status and dyspnea in
p a t i e n t sw i t hC O P D .I O Si se a s yt op e r f o r m ,o n l y
Table 3 Analysis of the relationships of health status and
dyspnea to pulmonary function, IOS and CT by stepwise
multiple regression analyses
SGRQ
symptoms activity impacts total MRC
Independent variables
FEV1 –– – – 0.03
RV/TLC – 0.02 –– 0.02
R5-R20 0.09 – 0.19 0.24 0.27
X5 – 0.26 –– –
LAA% –– – – 0.06
Cumulative r
2 0.09 0.28 0.19 0.24 0.38
All values represent coefficient of determination (r
2).
Missing data (–) indicate that independent variables were not statistically
significant.
FEV1 = forced expiratory volume in one second; RV = residual volume; TLC =
total lung capacity; R = resistance; X = reactance; LAA = low attenuation area;
SGRQ = St. George’s Respiratory Questionnaire; MRC = Medical Research
Council
Table 2 Analysis of the relationships between pulmonary function, IOS, CT, and patient-reported outcomes
SGRQ MRC HADS
symptom activity impacts total anxiety depression
FEV1 -0.24 -0.41 -0.29 -0.36 -0.37 ––
RV/TLC – 0.40 – 0.29 0.46 ––
DLCO/VA –– – – – – –
R20 –– – – – – –
R5-R20 0.31 0.49 0.44 0.49 0.51 ––
X5 -0.27 -0.51 -0.38 -0.46 -0.46 ––
LAA% – 0.27 –– 0.41 ––
WA% –– – – – – –
All values represent correlation coefficient (r).
Missing data (–) indicate that there were no statistically significant relationships.
FEV1 = forced expiratory volume in one second; RV = residual volume; TLC = total lung capacity; DLCO = carbon monoxide diffusing capacity; VA = alveolar
volume R = resistance; X = reactance; LAA = low attenuation area; WA = wall area; SGRQ = St. George’s Respiratory Questionnaire; MRC = Medical Research
Council; HADS = Hospital Anxiety and Depression Scale
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conventional pulmonary testing such as spirometry.
Therefore, IOS might be considered to be more useful
in routine practice for elderly patients with COPD. In
fact, IOS was recently used for detecting airway
abnormalities and for assessing pharmacological thera-
peutic efficacy in COPD and other respiratory disorders
[11-15,23-27].
Small airway disease (obstructive bronchiolitis) is one
of the central pathophysiological features of COPD [1].
Peripheral airway obstruction progressively traps air
during expiration, resulting in hyperinflation in COPD
[1]. In the present study, peripheral airway measure-
ments (R5-R20 and X5) by IOS consistently correlated
with both the degree of airflow limitation (FEV1)a n d
the degree of hyperinflation (RV/TLC) due to peripheral
airway obstruction. In contrast, large airway function
(R20) by IOS was not or only weakly correlated with the
degrees of airflow limitation and hyperinflation, and not
with health status and dyspnea. In COPD, it is now con-
sidered that hyperinflation rather than airflow limitation
is the main mechanism for exertional dyspnea [37], and
dyspnea is the major determinant of health status [5,6].
The significant association between hyperinflation and
patient-reported outcomes of dyspnea and poor health
status in patients with COPD has recently been
reviewed [38]. Thus, the present study indicates that the
peripheral airway may be important in determining pul-
monary impairment as well as health status and dyspnea
to some extent in patients with COPD, which can easily
be assessed using IOS.
CT is also a diagnostic useful method for patients with
COPD because it can easily quantitatively assess airway
and parenchymal pathology. First, we evaluated WA%,
an index of wall thickening in the large airway, to assess
airway function [20,32,39]. This parameter can also be
used in asthma for correlating airway parameters with
disease severity [31]. However, in the present study, WA
% was found not to correlate significantly with the
SGRQ and MRC scores, indicating that large airway
structural alterations on CT may not accurately reflect
patients’ perception of functional impairment. Secondly,
we used LAA% on CT as a quantitative index of emphy-
sema, another key feature of COPD. There are some
publications [40-42] on the relationship between emphy-
sema and the severity of COPD. However, multiple
regression analyses revealed that LAA% did not or only
weakly accounted for the SGRQ and MRC scores, inde-
pendent of R5-R20 or X5, indicating that emphysema
might not be as strong a determinant of health status or
dyspnea in COPD as peripheral airway measurements
by IOS.
Disturbed psychological status with anxiety and
depression is well-known in COPD. Previous studies
indicate that it is not significantly correlated with phy-
siological measurements such as FEV1,a r t e r i a lo x y g e n
pressure, exercise intolerance or daily physical activities
[4,8,43,44]. Additionally, we show here that, none of the
measurements of pulmonary function, IOS or CT was
significantly correlated with the HADS. This indicates
that psychological status should be evaluated separately
from airflow limitation, airway resistance and
emphysema.
The values for the coefficient determinations were
relatively small in Table 3 (cumulative r
2 = 0.09 to 0.38),
indicating that other factors might be contributing to
the outcome. In the present study, we did not assess
systemic consequences of COPD, such as exercise capa-
city and inflammatory biomarkers. These are known to
be significantly correlated with health status or dyspnea
independently FEV1 [5-7,45]. As COPD is regarded as a
systemic disease [1], in future, a more comprehensive
approach including these parameters might be informa-
tive for better understandings the systemic effects of
COPD compared to airway diseases.
There are some limitations in this study. First, we
used the actual values for IOS for the analysis, as defini-
tive predictive equations have not been established yet
[28]. There is a need to perform a large-scale study
across a wider age range to validate existing reference
values. Second, this study included only male patients,
as there are relatively few female patients. This may be
due to the gender difference in past smoking trends in
Japan, and possibly reflects the present features of Japa-
nese COPD patients. Thus, the generalization of the
Figure 1 Relationship between R5-R20 and SGRQ total score.
R5-R20 showed a significant positive correlation with SGRQ total
score (r
2 = 0.24, p < 0.001).
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the patients included in this study was relatively small.
However, our results have generated an interesting
hypothesis that small airways disease results in certain
symptomatology and this must be tested on new cohorts
of patients in order to validate the hypothesis.
Conclusions
In summary, measurements by IOS are significantly cor-
related with health status and dyspnea in patients with
COPD. Therefore, IOS might be useful to manage male
COPD patients assessing also their quality of daily life
and well-being.
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